Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Genetics & Genomics
African American women less likely to undergo genetic testing than white women
May 5th, 2005
There are large racial disparities in the use of genetic testing for breast and ovarian cancer in the U.S., according to a study in the April 13, 2005, issue of the Journal of the American Medical Association. Mutations in the genes BRCA1 or BRCA2 confer a significantly increased risk of breast and ovarian cancer. Women with a BRCA1/2 mutation have a lifetime breast cancer risk of 50 to 85% and a lifetime ovarian cancer risk of 14 to 40%. Testing for mutations in BRCA1/2 can provide individual information about breast and ovarian cancer risk that may affect decisions about prophylactic surgery, chemoprevention, and screening. Although clinical...
Source: Women's Health Weekly (2005-05-05)
|
